Solas BioVentures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Solas BioVentures/Activity

Solas BioVentures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Co-led Francis Medical's oversubscribed $80M Series C equity financing alongside Arboretum Ventures.

Francis Medical

Francis MedicalSolas BioVentures

prnewswire.comJAN 7, 2025

JAN 7, 2025

Team Change

Mark Christopherson, a 30-year medical device industry veteran, joined Solas BioVentures as Entrepreneur in Residence.

Mark Christopherson joined as Entrepreneur in Residence

Solas BioVentures

medicalalley.orgDEC 1, 2022

DEC 1, 2022

Exit

Portfolio company Aegea Medical, backed by Solas BioVentures, was acquired by CooperSurgical.

Aegea Medical

Aegea MedicalSolas BioVentures

businesswire.comFEB 1, 2021

FEB 1, 2021

Exit

Portfolio company NXThera was acquired by Boston Scientific for approximately $400M.

NXThera

NXTheraSolas BioVentures

massdevice.comMAR 2018

MAR 2018